Asthma Highlights Asthma Articles & Analysis: Older
281 news found
Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines on asthma management. Bedfont® manufactures the NObreath® Fractional exhaled Nitric Oxide (FeNO) device, which aids in diagnosing ...
Fungal Disease Awareness Week (FDAW) takes place from September 16th through the 20th. FDAW was created by the Centers for Disease Control and Prevention (CDC) to focus attention on the importance of recognizing, treating, and preventing serious fungal diseases. Fungal diseases are increasing worldwide, and signs suggest this trend will further increase warns the CDC. The agency also reports ...
The incidence of landscape fires has been rising globally, leading to increased exposure to landscape fire smoke (LFS) among millions of people. The inhalation of particulate matter (PM) from LFS is associated with adverse respiratory and cardiovascular outcomes. However, the mechanisms by which LFS impacts these functions remain inadequately understood. This blog focuses on a new ...
A recent survey found that close to 50% of households in Puerto Rico have at least one pet. For many, their pet is a part of the family, but unfortunately, many homes with pets also suffer from indoor environmental quality (IEQ) issues associated with pet odors and allergens. Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant ...
Aspergillosis is a potentially life-threatening condition caused by a fungal pathogen known as Aspergillus. It is a common type of mold found outdoors and in indoor environments. It can be found at excessive concentrations indoors when buildings suffer water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some ...
Particles Plus® instruments have once again been used by scientists for research into Nebulizer Inhalation Therapy. To test the administration of safe Nebulizer Inhalation Therapy, researchers monitored particle concentrations for different particle sizes with Particles Plus® Optical Particle Counters (OPC). Optical Particle Counters can measure particle size distribution and particle ...
The Centers for Disease Control and Prevention (CDC) created FDAW to highlight the importance of recognizing, treating, and preventing serious fungal diseases. ...
Vitalograph has joined forces with MedM Inc. to further enhance patient respiratory monitoring experience with digital health capabilities. The MedM health monitoring app is paired with Vitalograph’s Asthma-1 BT and Lung Monitor BT Smart devices. The app works as a digital asthma or lung function diary, helping users to better understand and manage their condition. Patient diaries like ...
Vitalograph is proud to announce that it a FeNO by NIOX® UK channel partner. Spirometry and FeNO present physicians with complementary diagnostic data to inform asthma care pathways. NIOX VERO® is non-invasive, simple-to-use, and provides rapid standardised FeNO measurements. It is a point-of-care device for assessing airway inflammation in patients with respiratory problems. With over ...
A potentially life-threatening condition known as aspergillosis is caused by a fungal pathogen named Aspergillus. It is a common type mold that can often be found outdoors and in indoor environments that have suffered water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, in Washington. Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
Throughout the United States, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as 2021. Tragically, there were also 4,145 deaths due to asthma the year before. These figures point to the toll that asthma has on individuals and families, as well as lost time in classrooms, decreased productivity in the workplace, and the tremendous medical ...
Throughout the United States, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as 2021. Tragically, there were also 4,145 deaths due to asthma the year before. These figures point to the toll asthma has on individuals and families, as well as lost time in classrooms, decreased productivity in the workplace and the tremendous medical costs ...
There are many known asthma triggers, but one of the more common ones is exposure to elevated levels of mold. ...
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses mold as a common asthma trigger and potential exposure risks in homes, schools and work environments. “8% of adults and 6.5% of children have asthma according to the Centers for Disease Control and Prevention,” said Paul Cochrane, ...
Lipids are essential to many body functions and serve as the building blocks for living cells. Alfa Chemistry has been an ISO 9001:2015 certified supplier of nearly all forms of lipids and fatty acids and continues to broaden its product lines by adding phospholipids, modified lipids, and functionalized lipids. These lipid molecules are recently added to the already well-established collection of ...
The Company also announces operational business update and reports its financial results for the second quarter ended September 30, 2022. Business Update Highlights “Our Q2 results demonstrate BioMark’s continued efforts to advance our technology platform with exceptional clinical data, expand our global partnerships, and accelerating the commercialization of its ...
We are happy to announce that the #simeox device is now commercially available in Canada. Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, ...
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. This clearance further validates the quality and clinical efficacy of the ...